von Weymarn LB - Search Results

1

The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.

Bloom J, Hinrichs AL, Wang JC, von Weymarn LB, Kharasch ED, Bierut LJ, Goate A, Murphy SE. Bloom J, et al. Among authors: von weymarn lb. Pharmacogenet Genomics. 2011 Jul;21(7):403-16. doi: 10.1097/FPC.0b013e328346e8c0. Pharmacogenet Genomics. 2011. PMID: 21597399 Free PMC article.

2

N-Nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes.

von Weymarn LB, Felicia ND, Ding X, Murphy SE. von Weymarn LB, et al. Chem Res Toxicol. 1999 Dec;12(12):1254-61. doi: 10.1021/tx990128y. Chem Res Toxicol. 1999. PMID: 10604876

3

Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3.

von Weymarn LB, Murphy SE. von Weymarn LB, et al. Chem Res Toxicol. 2001 Oct;14(10):1386-92. doi: 10.1021/tx010065v. Chem Res Toxicol. 2001. PMID: 11599930

4

CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6.

von Weymarn LB, Murphy SE. von Weymarn LB, et al. Xenobiotica. 2003 Jan;33(1):73-81. doi: 10.1080/0049825021000022302. Xenobiotica. 2003. PMID: 12519695

5

Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism.

von Weymarn LB, Brown KM, Murphy SE. von Weymarn LB, et al. J Pharmacol Exp Ther. 2006 Jan;316(1):295-303. doi: 10.1124/jpet.105.091306. Epub 2005 Sep 27. J Pharmacol Exp Ther. 2006. PMID: 16188955

6

Identification of N-(hydroxymethyl) norcotinine as a major product of cytochrome P450 2A6, but not cytochrome P450 2A13-catalyzed cotinine metabolism.

Brown KM, von Weymarn LB, Murphy SE. Brown KM, et al. Among authors: von weymarn lb. Chem Res Toxicol. 2005 Dec;18(12):1792-8. doi: 10.1021/tx0501381. Chem Res Toxicol. 2005. PMID: 16359169

7

Analysis of [3',3'-d(2)]-nicotine and [3',3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry.

Murphy SE, Villalta P, Ho SW, von Weymarn LB. Murphy SE, et al. Among authors: von weymarn lb. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 15;857(1):1-8. doi: 10.1016/j.jchromb.2007.06.018. Epub 2007 Jun 29. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17644451 Free PMC article.

8

CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Zhang X, D'Agostino J, Wu H, Zhang QY, von Weymarn L, Murphy SE, Ding X. Zhang X, et al. J Pharmacol Exp Ther. 2007 Nov;323(2):570-8. doi: 10.1124/jpet.107.127068. Epub 2007 Aug 1. J Pharmacol Exp Ther. 2007. PMID: 17671098

9

UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.

Berg JZ, von Weymarn LB, Thompson EA, Wickham KM, Weisensel NA, Hatsukami DK, Murphy SE. Berg JZ, et al. Among authors: von weymarn lb. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1423-31. doi: 10.1158/1055-9965.EPI-09-0959. Epub 2010 May 25. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20501767 Free PMC article.

10

Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.

Murphy SE, von Weymarn LB, Schutten MM, Kassie F, Modiano JF. Murphy SE, et al. Among authors: von weymarn lb. Cancer Prev Res (Phila). 2011 Nov;4(11):1752-60. doi: 10.1158/1940-6207.CAPR-11-0366. Epub 2011 Oct 25. Cancer Prev Res (Phila). 2011. PMID: 22027684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters